Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab.

Banke, Ann; Fosbøl, Emil L; Ewertz, Marianne; Videbæk, Lars; Dahl, Jordi S; Poulsen, Mikael Kjær; Cold, Søren; Jensen, Maj-Britt; Gislason, Gunnar H; Schou, Morten; Møller, Jacob E

Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab.

Banke, Ann; Fosbøl, Emil L; Ewertz, Marianne; Videbæk, Lars; Dahl, Jordi S; Poulsen, Mikael Kjær; Cold, Søren; Jensen, Maj-Britt; Gislason, Gunnar H; Schou, Morten; Møller, Jacob E.

Afiliação

Banke A; Department of Cardiology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark. Electronic address: Ann.Banke@rsyd.dk.
Fosbøl EL; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Ewertz M; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Oncology, Odense University Hospital, Odense, Denmark.
Videbæk L; Department of Cardiology, Odense University Hospital, Odense, Denmark.
Dahl JS; Department of Cardiology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Poulsen MK; Department of Cardiology, Odense University Hospital, Odense, Denmark.
Cold S; Department of Oncology, Odense University Hospital, Odense, Denmark.
Jensen MB; Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark.
Gislason GH; Department of Cardiology, Copenhagen University, Herlev and Gentofte Hospital, Hellerup, Denmark; Danish Heart Foundation, Copenhagen, Denmark.
Schou M; Department of Cardiology, Copenhagen University, Herlev and Gentofte Hospital, Herlev, Denmark.
Møller JE; Department of Cardiology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.

JACC Heart Fail ; 7(3): 217-224, 2019 03.

Article em En | MEDLINE | ID: mdl-30819377

Assuntos

Antineoplásicos Imunológicos/uso terapêutico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Neoplasias da Mama/tratamento farmacológico; Carcinoma Ductal de Mama/tratamento farmacológico; Cardiotoxicidade/epidemiologia; Insuficiência Cardíaca/epidemiologia; Mastectomia Segmentar; Trastuzumab/uso terapêutico; Adulto; Idoso; Neoplasias da Mama/metabolismo; Neoplasias da Mama/patologia; Carcinoma Ductal de Mama/metabolismo; Carcinoma Ductal de Mama/patologia; Cardiotoxicidade/etiologia; Quimioterapia Adjuvante; Estudos de Coortes; Ciclofosfamida/administração & dosagem; Dinamarca/epidemiologia; Docetaxel/administração & dosagem; Epirubicina/administração & dosagem; Feminino; Insuficiência Cardíaca/induzido quimicamente; Humanos; Incidência; Estudos Longitudinais; Pessoa de Meia-Idade; Receptor ErbB-2/metabolismo; Estudos Retrospectivos; Risco; Volume Sistólico

Palavras-chave

breast cancer; cardiotoxicity; epidemiology; heart failure; trastuzumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mastectomia Segmentar / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Ductal de Mama / Cardiotoxicidade / Trastuzumab / Antineoplásicos Imunológicos / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: JACC Heart Fail Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google